中国生物制药3月27日斥资3143.8万港元回购535万股

Group 1 - The core point of the article is that China Biopharmaceutical (01177) announced a share buyback plan, intending to repurchase 5.35 million shares at a cost of HKD 31.438 million [2] Group 2 - The share buyback is scheduled to take place on March 27, 2026 [2]